Clinical Trial Update: Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT [NA]

View source ↗

Summary

The document reports a clinical trial evaluating extended letermovir prophylaxis to prevent CMV reactivation in high-risk Chinese adults undergoing allogeneic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Letermovir (letermovir)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Cytomegalovirus Infections, CMV | NA | Status: RECRUITING